Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00351637
Status:
TERMINATED
Last Update Posted:
2012-01-19
First Post:
2006-07-11
Brief Title:
Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients
Sponsor:
Alberta Health services
Organization:
AHS Cancer Control Alberta
Study Overview
Official Title:
Sublingual Methadone for the Management of Cancer-related Procedure Pain in Inpatients a Phase II Multicenter Open Label Feasibility Study
Status:
TERMINATED
Status Verified Date:
2012-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Study suspended due to low accrual
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this Phase II study is to determine the feasibility of the dose titration and assessment protocol in the impatient population in the clinical setting of preventing or managing breakthrough pain before conducting an appropriately powered phase III study Thus the primary purpose of this study is to determine the proportion of patients who are successfully titrated to an effective dose of sublingual methadone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 22206 | None | None | None |